Ipride is indicated for the symptomatic treatment of;
gastrointestinal symptoms caused by gastric dysmotility and delayed gastric emptying, like the sensation of bloating, early satiety, postprandial fullness, upper abdominal pain or discomfort, anorexia, heartburn, nausea and vomiting; functional dyspepsia orchronic gastritis.
The following information see from the leaflet inside the pack:
Mechanism of action, Pharmacokinetics, Administration, Dosing consideration in special populations, contraindications, warnings and precautions, adverse reactions, drug interactions, use in the special populations, overdosage.
